105 related articles for article (PubMed ID: 11087732)
1. Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells.
Fernandes H; Cohen S; Bishayee S
J Biol Chem; 2001 Feb; 276(7):5375-83. PubMed ID: 11087732
[TBL] [Abstract][Full Text] [Related]
2. Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.
Latha K; Li M; Chumbalkar V; Gururaj A; Hwang Y; Dakeng S; Sawaya R; Aldape K; Cavenee WK; Bogler O; Furnari FB
Int J Cancer; 2013 Feb; 132(3):509-20. PubMed ID: 22729867
[TBL] [Abstract][Full Text] [Related]
3. Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.
Taylor ES; Pol-Fachin L; Lins RD; Lower SK
Proteins; 2017 Apr; 85(4):561-570. PubMed ID: 28019699
[TBL] [Abstract][Full Text] [Related]
4. Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2m(1) antibody.
Brunke C; Lohse S; Derer S; Peipp M; Boross P; Kellner C; Beyer T; Dechant M; Royle L; Liew LP; Leusen JH; Valerius T
MAbs; 2013; 5(6):936-45. PubMed ID: 24492345
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization.
Schmidt MHH; Furnari FB; Cavenee WK; Bögler O
Proc Natl Acad Sci U S A; 2003 May; 100(11):6505-10. PubMed ID: 12734385
[TBL] [Abstract][Full Text] [Related]
6. Ligand regulation of a constitutively dimeric EGF receptor.
Freed DM; Alvarado D; Lemmon MA
Nat Commun; 2015 Jun; 6():7380. PubMed ID: 26060020
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation-Dependent Conformations of the Disordered Carboxyl-Terminus Domain in the Epidermal Growth Factor Receptor.
Regmi R; Srinivasan S; Latham AP; Kukshal V; Cui W; Zhang B; Bose R; Schlau-Cohen GS
J Phys Chem Lett; 2020 Dec; 11(23):10037-10044. PubMed ID: 33179922
[TBL] [Abstract][Full Text] [Related]
8. Pockets as structural descriptors of EGFR kinase conformations.
Hasenahuer MA; Barletta GP; Fernandez-Alberti S; Parisi G; Fornasari MS
PLoS One; 2017; 12(12):e0189147. PubMed ID: 29228029
[TBL] [Abstract][Full Text] [Related]
9. Roles of glycosylation at the cancer cell surface: opportunities for large scale glycoproteomics.
Čaval T; Alisson-Silva F; Schwarz F
Theranostics; 2023; 13(8):2605-2615. PubMed ID: 37215580
[TBL] [Abstract][Full Text] [Related]
10. Novel Therapeutic Target Critical for SARS-CoV-2 Infectivity and Induction of the Cytokine Release Syndrome.
Harless WW; Lewis B; Qorri B; Abdulkhalek S; Szewczuk MR
Cells; 2023 May; 12(9):. PubMed ID: 37174732
[TBL] [Abstract][Full Text] [Related]
11. Nodakenin Induces ROS-Dependent Apoptotic Cell Death and ER Stress in Radioresistant Breast Cancer.
Kim TW
Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36830050
[No Abstract] [Full Text] [Related]
12. 6-Shogaol Overcomes Gefitinib Resistance via ER Stress in Ovarian Cancer Cells.
Kim TW; Lee HG
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768961
[TBL] [Abstract][Full Text] [Related]
13. Identification of α1,2-fucosylated signaling and adhesion molecules in head and neck squamous cell carcinoma.
Montesino B; Steenackers A; Lozano JM; Young GD; Hu N; Sackstein R; Chandler KB
Glycobiology; 2022 Apr; 32(5):441-455. PubMed ID: 34939118
[TBL] [Abstract][Full Text] [Related]
14. EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastoma.
Yeo AT; Jun HJ; Appleman VA; Zhang P; Varma H; Sarkaria JN; Charest A
Oncogene; 2021 Apr; 40(15):2682-2696. PubMed ID: 33707748
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of EGFR Resistance in Glioblastoma.
Pan PC; Magge RS
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187135
[TBL] [Abstract][Full Text] [Related]
16. N‑glycosylation and receptor tyrosine kinase signaling affect claudin‑3 levels in colorectal cancer cells.
Pérez AG; Andrade-Da-Costa J; De Souza WF; De Souza Ferreira M; Boroni M; De Oliveira IM; Freire-Neto CA; Fernandes PV; De Lanna CA; Souza-Santos PT; Morgado-Díaz JA; De-Freitas-Junior JCM
Oncol Rep; 2020 Oct; 44(4):1649-1661. PubMed ID: 32945502
[TBL] [Abstract][Full Text] [Related]
17. The Role of Hormones and Trophic Factors as Components of Preservation Solutions in Protection of Renal Function before Transplantation: A Review of the Literature.
Ostróżka-Cieślik A; Dolińska B
Molecules; 2020 May; 25(9):. PubMed ID: 32392782
[TBL] [Abstract][Full Text] [Related]
18. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
[TBL] [Abstract][Full Text] [Related]
19. Tunicamycin induces ER stress and inhibits tumorigenesis of head and neck cancer cells by inhibiting N-glycosylation.
Wang Y; Zhang L; He Z; Deng J; Zhang Z; Liu L; Ye W; Liu S
Am J Transl Res; 2020; 12(2):541-550. PubMed ID: 32194902
[TBL] [Abstract][Full Text] [Related]
20. EGFR
Rutkowska A; Stoczyńska-Fidelus E; Janik K; Włodarczyk A; Rieske P
J Oncol; 2019; 2019():1092587. PubMed ID: 32089685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
